![Why was the field games restarted? [VIDEO]](https://thegeek.hu/wp-content/uploads/sites/2/2023/06/thegeek-fable-2023-trailer.jpg "Why was the field games restarted? [VIDEO]")
László Pávics, head of the Nuclear Medicine Institute at Szeged University, explained that he opened a new opportunity in diagnosis and treatment to display typical biochemical differences in prostate cancer with adequate theoretical signs.
If radioactive radiation is used in a molecule against a cell therapeutic effect, it can treat metastasis for prostate cancer specifically in the bones, lymph nodes, soft parts and other organs. Psma therapy (prostate membrane antigen) is not an emanating with 177-Lutécium PSMA and the side effects are barely expected.
Their reaction was well with the first treatment
According to studies conducted on the results of about eight thousand prostate cancer patients, more than 50 percent of patients responded well for their first treatment, and 80 percent have achieved significant improvements with good quality of life.
In 2017, the institute's working group began dealing with the PSMA diagnostic setting application. In 2019, in cooperation with the university's urology clinic, the lymph node was removed with the first radioactive surgery. As of December 2020, the PET/CT diagnostic examination of the prostate membrane antigen began at the Nuclear Medicine Institute, which has become a central method for prostate cancer patients since 2022.
Currently, patients from all over the country come to Szeged. As a result of about eight years of development work, it was the first application, and now therapeutic of this procedure, it is possible with the help of the semester therapy clinic.
It will be possible to be implemented in the future
The treatment of radioactive prostate cancer is given intravenously, which currently includes two to three days of hospitalization. In the future, the intervention is planned. Six courses are used every six weeks, but the number of treatments can be increased as necessary.
Currently, at the SZTE Institute of Nuclear Medicine, three patients are treated in the new way, two of whom have already taken the first treatment, and they are fine. The university said in a statement that radiotherapy does not lead to other treatments, but there is an additional opportunity that extends to survival free of progress and improve the quality of life in patients with advanced and comprehensive disease.
Follow the index on Facebook as well!
